Bonetta Volume — High-Density HENM Filler for Facial Sculpting (2 × 1.1mL)

Bonetta Volume is ExoCoBio’s highest-density variant — 24 mg/mL cross-linked HA + 0.3% lidocaine with the most pronounced HENM cross-linking in the Bonetta range. Supplied as 2 × 1.1 mL syringes per box. Engineered for facial sculpting: cheek augmentation, jawline contouring, non-surgical nose reshaping, and chin augmentation with 12–24 month durability.

ExoCoBio Inc.’s proprietary cross-linking process produces a stabilised HA gel matrix engineered for sustained tissue retention. The technology balances viscoelasticity (firmness for projection) with extrusion smoothness (easier injection through the 27G needle). The result: predictable handling, consistent gel distribution, and 12–24 months durability in deep dermis placement.

Non-animal hyaluronic acid produced by bacterial fermentation. Endotoxin levels controlled below international safety thresholds. Stringent manufacturing under GMP-certified conditions minimises BDDE residue, heavy metals, and protein contaminants — reducing the risk of post-injection inflammation, granuloma formation, or hypersensitivity reactions in suitable patient profiles.

Non-animal hyaluronic acid produced by bacterial fermentation, cross-linked using ExoCoBio Inc.’s HENM Patented Cross-Linking (Highest Density) technology. The cross-linking process creates a stable, durable gel matrix that resists rapid enzymatic breakdown in tissue. Phosphate-buffered saline carries the gel at near-physiological pH.

Premixed local anaesthetic at the industry-standard 0.3% concentration. Reduces injection-site discomfort and eliminates the need for on-site mixing with separate lidocaine vials. The lidocaine itself wears off within hours of injection and does not affect long-term gel duration.

Cheek Augmentation

Primary indication. Deep subcutaneous and supraperiosteal placement for sustained midface volumising. 12–24 month durability per ExoCoBio data.

Jawline & Chin Contouring

Non-surgical jawline definition and chin augmentation. The high cross-linking density supports structural projection.

Nose Reshaping

Non-surgical rhinoplasty for nasal bridge and dorsum enhancement. Off-label use requiring advanced anatomical knowledge.

Deep Wrinkle Correction

Severe nasolabial folds and pronounced facial creases requiring high-firmness filler.

Manufacturer

• Brand: Bonetta
• Company: ExoCoBio Inc.
• Country: South Korea
• Established: 2017

Formula

• HA Source: Non-animal bacterial fermentation
• HA Concentration: 24 mg/mL
• Lidocaine: 0.3% (3 mg/mL) premixed
• Cross-linking: HENM Patented Cross-Linking (Highest Density)

Performance

• Duration: 12–24 months
• Injection Depth: Deep dermis · subcutaneous
• Recommended Needle: 27G
• Last Reviewed: May 2026

Approval & Storage

• Approvals: KFDA registered · GMP certified
• Packaging: 2 × 1.1 mL pre-filled syringes per box
• Storage: 2–25 °C, do not freeze
• Shelf life: 24 months unopened

Bonetta Volume Professional HA Filler is a prescription medical device for use only by licensed aesthetic practitioners. Common reactions include injection-site bruising, swelling, redness, and tenderness — generally resolving within days. Deep placement (subcutaneous and supraperiosteal layers) involves heightened anatomical awareness of facial vasculature; practitioners require access to hyaluronidase for emergency dissolution. Like all hyaluronic acid dermal fillers, treatment carries rare but serious vascular complication risks. Contraindicated in patients with known hypersensitivity to hyaluronic acid or lidocaine, active skin infection at the treatment site, pregnancy, or breastfeeding. Full contraindications, vascular complication protocols, aftercare, and emergency guidance are detailed on the dermal filler safety page.